EBEWE Pharma GmbH & Co. KG (batch release)

The drug is used to treat advanced or metastatic cancer of the testis, ovary, bladder, non-small cell and small cell lung cancer, as well as squamous cell carcinoma of the head and neck. It is also used for cervical tumors in combination with radiotherapy.

Dosage form: concentrate for infusion solution

ATC: L01XA01

The drug is used to treat widespread or metastatic cancer of the testis, ovary, bladder, non-small cell and small cell lung cancer, as well as squamous cell carcinoma of the head and neck. It is also used for cervical tumors in combination with radiotherapy.

Dosage form: concentrate for infusion solution

ATC: L01XA01

The drug is used in combination with other chemotherapeutic agents for the treatment of testicular cancer, small cell lung cancer, Hodgkin's disease, non-Hodgkin lymphoma, acute myeloid leukemia, malignant gestational trophoblastic disease, as well as ovarian cancer (non-epithelial in nature and platinum-resistant epithelial cancer).

Dosage form: concentrate for infusion solution

ATC: L01CB01

The drug is used to treat metastatic breast cancer, non-Hodgkin lymphoma, acute myeloid leukemia, as well as for the treatment of patients with highly active multiple sclerosis and certain types of prostate cancer.

Dosage form: concentrate for infusion solution

ATC: L01DB07